Skip to content

Intramuscular Pentazocine Versus Rectal Diclofenac for Pain Relief after Caesarean Section.

Intramuscular Pentazocine versus Rectal Diclofenac for Pain Relief after Caesarean Section: A Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402735520583
Enrollment
240
Registered
2024-02-13
Start date
2023-03-02
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caeserean section

Interventions

Sponsors

DR. ATONGO TERNGU JESSE
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who had caesarean delivery under spinal anesthesia that consented.

Exclusion criteria

Exclusion criteria: 1. Patients who had caesarean delivery under general anesthesia, epidural combined spinal 2. Patients with medical condition known to be potentially exacerbated by non-steroidal anti-inflammatory drugs such as peptic ulcer disease, renal .disease, Asthma liver disease 3. History of allergy to either of the study medications. 4. Patients with bleeding disorder. 5. Any patient who required special post-operative pain control such as sickle cell disease patient. 6. Patients who did not consent to the study.

Design outcomes

Primary

MeasureTime frame
1)To compare the effectiveness of intramuscular Pentazocine with rectal diclofenac sodium in post caesarean section pain relief.

Secondary

MeasureTime frame
2) To compare maternal satisfaction with rectal diclofenac sodium and with intramuscular Pentazocine. ;To determine the side effects/adverse effects experienced by patients in the two groups

Countries

Nigeria

Contacts

Public Contactwinifred Atongo

Analyst

ahungwawinifred@gmail.com+2348105270558

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026